Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A randomized phase 2b trial of baricitinib, an oral Janus kinase (<scp>JAK</scp>) 1/JAK2 inhibitor, in patients with moderate‐to‐severe psoriasis
PaperCitations, authors & open-access status
A randomized phase 2b trial of baricitinib, an oral Janus kinase (<scp>JAK</scp>) 1/JAK2 inhibitor, in patients with moderate‐to‐severe psoriasis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 261 citations, 2016 year and hybrid oa status.
261
Citations
2016
Year
hybrid
OA Status